White Paper

Navigating Upstream AAV Production: A Checklist For Efficient And Reliable Gene Therapy Manufacturing

Source: Sartorius

By Catherine Buchere, Kathrin Teschner, David Ede, and Katy McLaughlin

Adeno-associated viruses AAV GettyImages-1322096218

Initially developed to treat rare and ultra-rare diseases, there is growing interest in developing gene therapies for more common indications. This shift necessitates the adoption of new tools and strategies to support higher yields, larger scales, and traceable biomanufacturing processes that produce high-quality products.

The leading platform for delivering in vivo gene therapy is adeno-associated viruses (AAVs), making the establishment of reliable AAV production processes critically important for clinical applications. Shortening the time-to-clinic is a top priority for gene therapy manufacturers due to the rapid pace of the market and intense competition. Although there is pressure to expedite process development activities in favor of moving quickly into production, it is essential to consider key principles at each developmental phase.

Upstream AAV process development is costly and time-consuming, and there are numerous decisions to be made and process parameters to optimize. Therefore, careful consideration from early research through to clinical production is required for successful expansion and production. Gain insight into how to design and execute an efficient upstream AAV production process. This white paper offers guidance for drug developers as well as a checklist to ensure all appropriate factors are considered at each phase, thereby mitigating risks throughout AAV process development.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online